Bank of Hawaii’s Pfizer PFE Stock Holding History

Bank of Hawaii’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Hold	41,818	–	–	0.05%	141
2026 Q1	$1.17M	Buy	41,818 +3,884	+10%	+$103K	0.06%	118
2025 Q4	$945K	Sell	37,934 -636	-2%	-$16K	0.05%	140
2025 Q3	$983K	Sell	38,570 -7,433	-16%	-$183K	0.05%	140
2025 Q2	$1.12M	Sell	46,003 -17,878	-28%	-$417K	0.06%	127
2025 Q1	$1.62M	Sell	63,881 -5,977	-9%	-$156K	0.09%	93
2024 Q4	$1.85M	Sell	69,858 -911	-1%	-$24.7K	0.1%	88
2024 Q3	$2.05M	Buy	70,769 +564	+0.8%	+$16.5K	0.09%	97
2024 Q2	$1.96M	Sell	70,205 -12,851	-15%	-$354K	0.09%	90
2024 Q1	$2.3M	Sell	83,056 -4,393	-5%	-$122K	0.11%	78
2023 Q4	$2.52M	Sell	87,449 -50,580	-37%	-$1.53M	0.13%	70
2023 Q3	$4.58M	Sell	138,029 -3,563	-3%	-$126K	0.26%	47
2023 Q2	$5.19M	Sell	141,592 -3,929	-3%	-$153K	0.29%	44
2023 Q1	$5.94M	Buy	145,521 +2,396	+2%	+$103K	0.34%	35
2022 Q4	$7.33M	Buy	143,125 +647	+0.5%	+$31K	0.45%	30
2022 Q3	$6.24M	Sell	142,478 -3,359	-2%	-$163K	0.42%	28
2022 Q2	$7.65M	Buy	145,837 +1,222	+0.8%	+$62.3K	0.49%	27
2022 Q1	$7.49M	Sell	144,615 -2,418	-2%	-$125K	0.41%	30
2021 Q4	$8.68M	Sell	147,033 -13,664	-9%	-$677K	0.45%	29
2021 Q3	$6.91M	Sell	160,697 -6,215	-4%	-$275K	0.39%	32
2021 Q2	$6.54M	Sell	166,912 -1,404	-0.8%	-$54.6K	0.37%	32
2021 Q1	$6.1M	Sell	168,316 -4,080	-2%	-$145K	0.37%	32
2020 Q4	$6.35M	Sell	172,396 -25,362	-13%	-$930K	0.41%	32
2020 Q3	$6.89M	Buy	197,758 +1,603	+0.8%	+$56.2K	0.5%	28
2020 Q2	$6.09M	Buy	196,155 +3,000	+2%	+$102K	0.46%	35
2020 Q1	$5.98M	Sell	193,155 -1,118	-0.6%	-$38.1K	0.52%	30
2019 Q4	$7.22M	Sell	194,273 -19,007	-9%	-$677K	0.5%	35
2019 Q3	$7.27M	Sell	213,280 -10,428	-5%	-$379K	0.54%	35
2019 Q2	$9.2M	Sell	223,708 -2,376	-1%	-$94.3K	0.69%	27
2019 Q1	$9.11M	Buy	226,084 +3,345	+2%	+$134K	0.69%	26
2018 Q4	$9.22M	Buy	222,739 +11,006	+5%	+$457K	0.8%	21
2018 Q3	$8.85M	Buy	211,733 +2,127	+1%	+$81.9K	0.68%	28
2018 Q2	$7.21M	Buy	209,606 +98	+0%	+$3.35K	0.6%	31
2018 Q1	$7.05M	Buy	209,508 +5,154	+3%	+$177K	0.59%	35
2017 Q4	$7.02M	Sell	204,354 -6,804	-3%	-$232K	0.57%	38
2017 Q3	$7.15M	Buy	211,158 +6,175	+3%	+$198K	0.6%	40
2017 Q2	$6.53M	Sell	204,983 -10,349	-5%	-$326K	0.57%	42
2017 Q1	$6.99M	Sell	215,332 -1,072	-0.5%	-$33.8K	0.63%	39
2016 Q4	$6.67M	Sell	216,404 -5,780	-3%	-$176K	0.62%	39
2016 Q3	$7.14M	Sell	222,184 -4,570	-2%	-$153K	0.66%	43
2016 Q2	$7.58M	Sell	226,754 -14,222	-6%	-$454K	0.82%	31
2016 Q1	$6.78M	Sell	240,976 -14,831	-6%	-$424K	0.73%	35
2015 Q4	$7.83M	Buy	255,807 +37,474	+17%	+$1.18M	0.9%	31
2015 Q3	$6.51M	Buy	218,333 +9,450	+5%	+$303K	0.76%	36
2015 Q2	$6.64M	Sell	208,883 -12,283	-6%	-$400K	0.69%	37
2015 Q1	$7.3M	Sell	221,166 -27,567	-11%	-$876K	0.71%	35
2014 Q4	$7.35M	Sell	248,733 -18,217	-7%	-$522K	0.69%	31
2014 Q3	$7.49M	Buy	266,950 +348	+0.1%	+$9.77K	0.7%	32
2014 Q2	$7.51M	Sell	266,602 -1,410	-0.5%	-$40.2K	0.71%	31
2014 Q1	$8.17M	Sell	268,012 -7,235	-3%	-$216K	0.81%	26
2013 Q4	$8M	Buy	275,247 +12,693	+5%	+$369K	0.81%	27
2013 Q3	$7.16M	Sell	262,554 -8,752	-3%	-$238K	0.75%	30
2013 Q2	$7.21M	Buy	+271,306	New	+$7.5M	0.78%	33

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of Hawaii's PFE Position: Q2 2026 in Review

Bank of Hawaii held its Pfizer (PFE) position steady in Q2 2026 at 41,818 shares worth $1.01M. The position accounts for 0.05% of the portfolio, ranked #141.

Bank of Hawaii first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.22M in Q4 2018. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Bank of Hawaii held 41,818 shares of Pfizer worth $1.01M as of Q2 2026.
Bank of Hawaii left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.05% of Bank of Hawaii's portfolio in Q2 2026, its #141 holding.
Bank of Hawaii first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Bank of Hawaii's Pfizer position peaked at $9.22M in Q4 2018.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bank of Hawaii's 13F filing for Q2 2026, filed 14 Aug 2026.